EligibleTrials

Mindfulness in Chronic Kidney Disease

Recruiting · NCT04099992 · Interventional (participants receive a specific treatment) · Lead sponsor: Emory University

View the official record on ClinicalTrials.gov →
Chronic kidney disease

Interventions studied

Health enhancement program (HEP)Mindfulness-based stress reduction (MBSR)Sham-transcutaneous Vagus Nerve Stimulation (tVNS)Transcutaneous Vagus Nerve Stimulation (tVNS)

What this trial is about

This study will test whether mindfulness meditation (MM) improves sympathetic function in chronic kidney disease (CKD) and whether transcutaneous vagus nerve stimulation (tVNS) optimizes the sympatho-inhibitory effects of mindfulness meditation (MM) and restores autonomic balance in CKD patients.

Who can take part

Age range
40 Years to 80 Years
Sex
All (male and female)
Healthy volunteers
No - a diagnosis or condition is required
Phase
Not applicable (e.g. observational or device study)
Study type
Interventional (participants receive a specific treatment)

Inclusion criteria

Exclusion criteria

Where it is running

1 location listed across 1 US state.

Read the full protocol, contacts and eligibility on ClinicalTrials.gov →

Get notified when new trials open

One email when new recruiting trials are added. Unsubscribe anytime.